Bionext wants to raise 5 million for the commercialization of its new service

Press Release from Le Journal des Entreprises Bionext, a French biotechnology company located in Strasbourg, has just launched a Web platform dedicated to pharmaceutical research and now ambitions to raise five million for its commercialization. See more: Source

Continue reading

BIONEXT Launches BioSight

Bionext Launches BioSight: an Online Platform That Will Revolutionize Pharmaceutical Research Helps companies accelerate the development of new medications by reducing the failure rate during the clinical phase. Bionext, a bioinformatics company, announces today the launch of BioSight, an online bio-simulation platform designed for efficient identification of possible side effects of potential drug treatments on the human body. As result of fifteen years of molecular biology R&D, BioSight uses a patented algorithm that is able to predict all of the potential biological targets that are at risk of interacting with a potential drug treatment.

Continue reading

BIONEXT at Bio International Convention 2017

BIONEXT will be part on June 19-22th of Bio San Diego 2017. More information on Bio Convention website.

Continue reading